How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

The frontier model is a commodity. The companies winning are the ones that own distribution, and venture capital is paying up ...

Building a model capable of RSI would require automating a range of specialist tasks currently carried out by humans. At present data scientists work on the theory of AI and coders put it into ...

Abstract: Return-oriented programming (ROP) attacks pose a significant threat to the control-flow integrity (CFI) of Internet of Things (IoT) devices, which operate in resource-constrained ...

May 25, 2026 — Canton Foundation, Toss, BitGo Among Co-Hosts at Private Event; Token Launch Slated for Second Half of 2026. On May 21, ARIQO, an on-chain financial platform, made its first public ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Even as leading AI providers like OpenAI and Anthropic battle over the compute to train and release ever larger, more powerful models, other labs are going in a different direction — pursuing the ...

In Meta's Q1 earnings call, Barclays analyst Ross Sandler asked Zuckerberg about the company's strategy for AI coding and "the recursive self-improvement loop." Zuckerberg replied that he thinks that ...

Good afternoon. My name is Christa, and I will be your conference operator today. At this time, I would like to welcome everyone to Meta's First Quarter 2026 Earnings Conference Call. [Operator ...